Back to Authors

Douvoyiannis, Miltiadis

https://orcid.org/0000-0003-4916-7306

A5074912513 | I24571045

Mayo Clinic

University of North Dakota

Citations 2

Increased Macrolide-Resistant Mycoplasma pneumoniae Infections and Response to Doxycycline in Midwest United States

Clinical Pediatrics | December 16, 2025 | Volume: 65 | Issue: 2 | Pages: 153-157

10.1177/00099228251392096 | PMID 41400014

37 cases of Mycoplasma pneumoniae pneumonia were diagnosed in children in North Dakota, over 3.5 months (35 by PCR); 44% harbored macrolide-resistance. Children with macrolide-resistant M. pneumoniae had a longer period of coughing prior to diagnosis (+ 3.9 days, p=0.048), a longer duration of illness (+ 5.4 days, p=0.011) and earlier resolution of fever after initiation of doxycycline (- 0.92 days, p=0.025) compared to those without macrolide resistant M. pneumoniae.
Macrolide-Resistant Mycoplasma pneumoniae, North Dakota 2024

Journal of the Pediatric Infectious Diseases Society | November 21, 2024 | Volume: 14 | Issue: 1 | Pages: No page available

10.1093/jpids/piae117 | PMID 39570300

Abstract A cluster of macrolide-resistant Mycoplasma pneumoniae -causing community-acquired pneumonia was observed in children in North Dakota in 2024. Suspicion was raised by non-response to macrolides, with confirmation via a polymerase-chain reaction assay. Prompt improvement occurred after the initiation of alternative antibiotics.